...
首页> 外文期刊>The Journal of Experomental Medicine >Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor.
【24h】

Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor.

机译:白介素(IL)15是一种新型的细胞因子,可通过IL-2受体的成分激活人类自然杀伤细胞。

获取原文

摘要

Interleukin 15 (IL-15) is a novel cytokine that has recently been cloned and expressed. Whereas it has no sequence homology with IL-2, IL-15 interacts with components of the IL-2 receptor (IL-2R). In the present study we performed a functional analysis of recombinant IL-15 on phenotypically and functionally distinct populations of highly purified human natural killer (NK) cells. The CD56bright subset of human NK cells constitutively expresses the high affinity IL-2R and exhibits a brisk proliferative response after the binding of picomolar amounts of IL-2. Using a proliferation assay, IL-15 demonstrated a very steep dose-response curve that was distinct from the dose-response curve for IL-2. The proliferative effects of IL-15 could be abrogated by anti-IL-2R beta (p75), but not by anti-IL-2R alpha (p55). The proliferative effects of IL-2 on CD56bright NK cells could be inhibited by both antibodies. CD56dim NK cells express the intermediate affinity IL-2R in the absence of the high affinity IL-2R. Activation of CD56dim NK cells by IL-15 was similar to that of IL-2 as measured by enhanced NK cytotoxic activity, antibody-dependent cellular cytotoxicity, and NK cell production of interferon gamma, tumor necrosis factor alpha, and granulocyte/macrophage colony-stimulating factor. The IL-15-enhanced NK cytotoxic activity could be completely blocked by anti-IL-2R beta monoclonal antibody. The binding of radiolabeled IL-2 and IL-15 to CD56dim NK cells was inhibited in the presence of anti-IL-2R beta. Scatchard analysis of radiolabeled IL-15 and IL-2 binding to NK-enriched human lymphocytes revealed the presence of high and intermediate affinity receptors for both ligands. IL-15 is a ligand that activates human NK cells through components of the IL-2R in a pattern that is similar but not identical to that of IL-2. Unlike IL-2, IL-15 is produced by activated monocytes/macrophages. The discovery of IL-15 may increase our understanding of how monocytes/macrophages participate in the regulation of NK cell function.
机译:白介素15(IL-15)是一种新型的细胞因子,最近已被克隆和表达。尽管它与IL-2没有序列同源性,但IL-15与IL-2受体(IL-2R)的成分相互作用。在本研究中,我们对高纯度人类自然杀伤(NK)细胞的表型和功能上不同的群体进行了重组IL-15的功能分析。人NK细胞的CD56bright亚组组成型表达高亲和力的IL-2R,并在皮摩尔量的IL-2结合后表现出轻快的增殖反应。使用增殖测定,IL-15表现出非常陡峭的剂量反应曲线,与IL-2的剂量反应曲线不同。抗IL-2R beta(p75)可以​​消除IL-15的增殖作用,而抗IL-2R alpha(p55)不能消除IL-15的增殖作用。两种抗体均可抑制IL-2对CD56bright NK细胞的增殖作用。在不存在高亲和力IL-2R的情况下,CD56dim NK细胞表达中等亲和力IL-2R。 IL-15对CD56dim NK细胞的激活与IL-2相似,这通过增强的NK细胞毒性活性,抗体依赖性细胞的细胞毒性以及干扰素γ,肿瘤坏死因子α和粒细胞/巨噬细胞集落-刺激因素。抗IL-2Rβ单克隆抗体可以完全阻断IL-15增强的NK细胞毒性活性。在抗IL-2R beta的存在下,放射性标记的IL-2和IL-15与CD56dim NK细胞的结合被抑制。放射性标记的IL-15和IL-2与富集NK的人淋巴细胞的Scatchard分析表明,两种配体都存在高亲和力和中等亲和力受体。 IL-15是一种配体,其以与IL-2相似但不同的方式通过IL-2R的成分激活人NK细胞。与IL-2不同,IL-15由活化的单核细胞/巨噬细胞产生。 IL-15的发现可能增加我们对单核细胞/巨噬细胞如何参与NK细胞功能调节的了解。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号